Devonian Health Group Inc.
DVHGF · OTC
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Revenue | $17,027 | $17,816 | $2,345 | $2,305 |
| % Growth | -4.4% | 659.6% | 1.7% | – |
| Cost of Goods Sold | $15,032 | $11,826 | $1,453 | $1,744 |
| Gross Profit | $8,559 | $5,989 | $892 | $561 |
| % Margin | 50.3% | 33.6% | 38% | 24.3% |
| R&D Expenses | $2,006 | $1,288 | $1,354 | $779 |
| G&A Expenses | $7,323 | $5,560 | $3,862 | $2,695 |
| SG&A Expenses | $7,323 | $5,560 | $3,862 | $2,695 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $256 | $0 | $0 | $0 |
| Operating Expenses | $9,586 | $6,848 | $5,217 | $3,474 |
| Operating Income | -$1,027 | -$858 | -$4,283 | -$2,913 |
| % Margin | -6% | -4.8% | -182.6% | -126.3% |
| Other Income/Exp. Net | -$4,561 | -$366 | -$316 | -$536 |
| Pre-Tax Income | -$5,588 | -$1,225 | -$4,600 | -$3,448 |
| Tax Expense | $424 | $0 | $0 | $0 |
| Net Income | -$4,340 | -$1,225 | -$4,600 | -$3,448 |
| % Margin | -25.5% | -6.9% | -196.1% | -149.6% |
| EPS | -0.029 | -0.008 | -0.034 | -0.029 |
| % Growth | -253% | 75.6% | -17.2% | – |
| EPS Diluted | -0.029 | -0.008 | -0.034 | -0.029 |
| Weighted Avg Shares Out | 148,223 | 147,110 | 135,287 | 118,907 |
| Weighted Avg Shares Out Dil | 148,223 | 147,110 | 135,566 | 119,028 |
| Supplemental Information | – | – | – | – |
| Interest Income | $201 | $74 | $184 | $40 |
| Interest Expense | $185 | $380 | $460 | $937 |
| Depreciation & Amortization | $346 | $673 | $423 | $864 |
| EBITDA | -$5,104 | -$172 | -$3,716 | -$1,647 |
| % Margin | -30% | -1% | -158.5% | -71.5% |